001     127805
005     20240228140950.0
024 7 _ |a pmid:25518914
|2 pmid
024 7 _ |a pmc:PMC4317580
|2 pmc
037 _ _ |a DKFZ-2017-03827
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Woehrer, Adelheid
|b 0
245 _ _ |a Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014.
260 _ _ |a Deisenhofen, München
|c 2015
|b Dustri-Verl.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1532349113_11869
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The Brain Tumor Epidemiology Consortium (BTEC) is an open scientific forum, which fosters the development of multi-center, international and inter-disciplinary collaborations. BTEC aims to develop a better understanding of the etiology, outcomes, and prevention of brain tumors (http://epi.grants.cancer.gov/btec/). The 15th annual Brain Tumor Epidemiology Consortium Meeting, hosted by the Austrian Societies of Neuropathology and Neuro-oncology, was held on September 9 - 11, 2014 in Vienna, Austria. The meeting focused on the central role of brain tumor epidemiology within multidisciplinary neuro-oncology. Knowledge of disease incidence, outcomes, as well as risk factors is fundamental to all fields involved in research and treatment of patients with brain tumors; thus, epidemiology constitutes an important link between disciplines, indeed the very hub. This was reflected by the scientific program, which included various sessions linking brain tumor epidemiology with clinical neuro-oncology, tissue-based research, and cancer registration. Renowned experts from Europe and the United States contributed their personal perspectives stimulating further group discussions. Several concrete action plans evolved for the group to move forward until next year's meeting, which will be held at the Mayo Clinic at Rochester, MN, USA.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to PubMed,
700 1 _ |a Lau, Ching C
|b 1
700 1 _ |a Prayer, Daniela
|b 2
700 1 _ |a Bauchet, Luc
|b 3
700 1 _ |a Rosenfeld, Myrna
|b 4
700 1 _ |a Capper, David
|0 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
|b 5
|u dkfz
700 1 _ |a Fisher, Paul G
|b 6
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 7
|u dkfz
700 1 _ |a Müller, Martin
|b 8
700 1 _ |a Kros, Johan M
|b 9
700 1 _ |a Kruchko, Carol
|b 10
700 1 _ |a Wiemels, Joseph
|b 11
700 1 _ |a Wrensch, Margaret
|b 12
700 1 _ |a Danysh, Heather E
|b 13
700 1 _ |a Zouaoui, Sonia
|b 14
700 1 _ |a Heck, Julia E
|b 15
700 1 _ |a Johnson, Kimberly J
|b 16
700 1 _ |a Qi, Xiaoyang
|b 17
700 1 _ |a O'Neill, Brian P
|b 18
700 1 _ |a Afzal, Samina
|b 19
700 1 _ |a Scheurer, Michael E
|b 20
700 1 _ |a Bainbridge, Matthew N
|b 21
700 1 _ |a Nousome, Darryl
|b 22
700 1 _ |a Bahassi, El Mustapha
|b 23
700 1 _ |a Hainfellner, Johannes A
|b 24
700 1 _ |a Barnholtz-Sloan, Jill S
|b 25
700 1 _ |a Consortium, Brain Tumor Epidemiology
|b 26
|e Collaboration Author
773 _ _ |g Vol. 34, no. 1
|0 PERI:(DE-600)2007408-6
|n 1
|p 40-46
|t Clinical neuropathology
|v 34
|y NN
|x 0722-5091
909 C O |p VDB
|o oai:inrepo02.dkfz.de:127805
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN NEUROPATHOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)G380-20160331
|k G380
|l KKE Neuropathologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)G380-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21